About SCHOTT Pharma

Over 130 years ago, Otto Schott set out to improve the world with groundbreaking glass innovations, fueling science and inspiring progress. This pioneering spirit created a global leader in the pharmaceutical industry: SCHOTT Pharma. We design solutions grounded in science to ensure that medicines are safe and easy to use for people around the world – because human health matters.

Our ambition: Far beyond manufacturing

Pharmaceutical manufacturing experts know that our products enable medicines to reach the patient in a safe, fast, and reliable manner. Based on the requirements of different drug formulations, our solutions are made of borosilicate glass or high-grade pharmaceutical COC polymer.

Our locations worldwide

SCHOTT Pharma employs around 4,700 scientists, pioneers, and problem solvers in North America, Europe, Asia, and Latin America. We operate 16 GMP-compliant manufacturing sites spread across the globe to serve our clients locally and shorten delivery times.

A strong heritage

SCHOTT Pharma is part of SCHOTT AG, a multinational glass company specializing in the manufacture of glass and glass-ceramics. Headquartered in Mainz, Germany, it is owned by the Carl Zeiss Foundation. The corporate governance statements for SCHOTT Pharma AG & Co. KGaA (Erklärung zur Unternehmensführung) can be found here.

SCHOTT is represented in 34 countries and serves a multitude of industries from Healthcare, Home Appliances & Living, and Consumer Electronics to Semiconductors & Datacom, Optics, Industry & Energy, Automotive, and Astronomy & Aerospace. In the fiscal year 2021, our 17,300 employees generated sales of 2.5 billion euros.

As a foundation company, SCHOTT has anchored responsibility for employees, society, and the environment deeply in its DNA. The goal is to become a climate-neutral company by 2030.